Abstract Submission
Potential submissions will cover the full scope of medical image analysis applied to women’s reproductive health, from early detection and diagnosis, to computer-aided diagnosis, to handling data, labels, annotations and segmentations, evaluation methods, clinical validity like performance metrics, multimodal approaches, for example fusing ultrasound + MRI or other sensors + MRI, AI-based interventions for laparoscopic surgery (endometriosis, cysts, fibroids), uterine artery embolization prediction (for fibroids) and post-surgery analysis methods, applied for example to histopathological uterine or ovarian tissue.
​
We particularly encourage the submission of abstracts focused on novel ideas, early-stage work, feasibility studies, or even unsuccessful attempts - with the goal of receiving feedback from the community. Rather than full papers, these abstracts are intended to spotlight promising concepts, share preliminary results or challenges, and help assess potential and limitations through open discussion. Submissions may include proof-of-concept work, pilot data, or methods in development. This format is ideal for gaining early insights, exploring feasibility, and refining directions before a full paper submission.
​​
Keywords - Reproductive Health, Women’s Health, Imaging, Endometriosis, Adenomyosis, Cervical Cancer, Uterine Myomas/Fibroids, Pelvic Inflammatory Diseases, PCOs/PCODs
​
Deadline
-
9th of July 2025, 12 PM CEST: Full Paper Submission Deadline
-
July 26th, 9 PM CEST: Reviews due
-
July 2025: Notification of Paper Acceptance
-
​End of July 2025: Camera-ready Abstract due
-
September 2025: CAPI 2025.
​​​​​
Anonymity Guidelines
The anonymity guidelines require to remove the author and affiliation information from the title page and the abstract's header. The authors have to make references to their work anonymously, by citing it in the third person. If the anonymity requirements are not fulfilled, automatic abstract rejection is performed.
​
Submission Instructions
Abstracts will be limited to two pages of Springer LNCS format . All abstracts will be reviewed by at least two reviewers with a double blind policy. The review period will begin after submission and decisions will be notified by mid-July 2025.
​
Abstracts will be selected based on relevance, significance and novelty of results, technical merit, and clarity of presentation. Submissions should be 2 pages or less, including references, in the final LNCS paper template.
​​
​